Logo image of NAC

NUVEEN CA QLTY MUNI INC (NAC) Stock Price, Quote, News and Overview

NYSE:NAC - New York Stock Exchange, Inc. - US67066Y1055 - Currency: USD

11.19  -0.04 (-0.36%)

Fundamental Rating

2

Overall NAC gets a fundamental rating of 2 out of 10. We evaluated NAC against 0 industry peers in the Unkown industry. NAC may be in some trouble as it scores bad on both profitability and health. NAC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year NAC was profitable.
In the past year NAC had a positive cash flow from operations.
In multiple years NAC reported negative net income over the last 5 years.
Each year in the past 5 years NAC had a positive operating cash flow.
NAC Yearly Net Income VS EBIT VS OCF VS FCFNAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

Industry RankSector Rank
ROA 1.51%
ROE 2.58%
ROIC 1.7%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NAC Yearly ROA, ROE, ROICNAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

NAC's Profit Margin has improved in the last couple of years.
NAC's Operating Margin has declined in the last couple of years.
In the last couple of years the Gross Margin of NAC has declined.
Industry RankSector Rank
OM 48.18%
PM (TTM) 34.01%
GM 48.89%
OM growth 3Y-13.04%
OM growth 5Y-6.45%
PM growth 3YN/A
PM growth 5Y14.26%
GM growth 3Y-13.4%
GM growth 5Y-6.64%
NAC Yearly Profit, Operating, Gross MarginsNAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

3

2. Health

2.1 Basic Checks

NAC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NAC Yearly Shares OutstandingNAC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M
NAC Yearly Total Debt VS Total AssetsNAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.82, we must say that NAC is in the distress zone and has some risk of bankruptcy.
NAC has a debt to FCF ratio of 18.61. This is a negative value and a sign of low solvency as NAC would need 18.61 years to pay back of all of its debts.
A Debt/Equity ratio of 0.70 indicates that NAC is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 18.61
Altman-Z 0.82
ROIC/WACCN/A
WACCN/A
NAC Yearly LT Debt VS Equity VS FCFNAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

NAC has a Current Ratio of 2.20. This indicates that NAC is financially healthy and has no problem in meeting its short term obligations.
NAC has a Quick Ratio of 2.20. This indicates that NAC is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 2.2
NAC Yearly Current Assets VS Current LiabilitesNAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

1

3. Growth

3.1 Past

NAC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -58.44%.
The Earnings Per Share has been growing by 11.84% on average over the past years. This is quite good.
Looking at the last year, NAC shows a small growth in Revenue. The Revenue has grown by 4.46% in the last year.
Measured over the past years, NAC shows a decrease in Revenue. The Revenue has been decreasing by -2.23% on average per year.
EPS 1Y (TTM)-58.44%
EPS 3YN/A
EPS 5Y11.84%
EPS Q2Q%-97.37%
Revenue 1Y (TTM)4.46%
Revenue growth 3Y0.45%
Revenue growth 5Y-2.23%
Sales Q2Q%0%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NAC Yearly Revenue VS EstimatesNAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 34.97, NAC can be considered very expensive at the moment.
When comparing the Price/Earnings ratio of NAC to the average of the S&P500 Index (27.41), we can say NAC is valued slightly more expensively.
Industry RankSector Rank
PE 34.97
Fwd PE N/A
NAC Price Earnings VS Forward Price EarningsNAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 24.17
EV/EBITDA N/A
NAC Per share dataNAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)2.95
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

NAC has a Yearly Dividend Yield of 7.88%, which is a nice return.
NAC's Dividend Yield is rather good when compared to the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 7.88%

5.2 History

NAC has been paying a dividend for at least 10 years, so it has a reliable track record.
NAC has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
NAC Yearly Dividends per shareNAC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

NAC pays out 143.76% of its income as dividend. This is not a sustainable payout ratio.
DP143.76%
EPS Next 2YN/A
EPS Next 3YN/A
NAC Yearly Income VS Free CF VS DividendNAC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
NAC Dividend Payout.NAC Dividend Payout, showing the Payout Ratio.NAC Dividend Payout.PayoutRetained Earnings

NUVEEN CA QLTY MUNI INC

NYSE:NAC (7/11/2025, 8:04:00 PM)

11.19

-0.04 (-0.36%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-02 2022-05-02
Earnings (Next)N/A N/A
Inst Owners16.11%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.62B
Analysts45
Price TargetN/A
Short Float %0.3%
Short Ratio1.05
Dividend
Industry RankSector Rank
Dividend Yield 7.88%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP143.76%
Div Incr Years1
Div Non Decr Years1
Ex-Date06-13 2025-06-13 (0.0735)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 34.97
Fwd PE N/A
P/S 12
P/FCF 24.17
P/OCF 24.17
P/B 0.91
P/tB 0.91
EV/EBITDA N/A
EPS(TTM)0.32
EY2.86%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.46
FCFY4.14%
OCF(TTM)0.46
OCFY4.14%
SpS0.93
BVpS12.31
TBVpS12.31
PEG (NY)N/A
PEG (5Y)2.95
Profitability
Industry RankSector Rank
ROA 1.51%
ROE 2.58%
ROCE 2.16%
ROIC 1.7%
ROICexc 1.7%
ROICexgc 1.7%
OM 48.18%
PM (TTM) 34.01%
GM 48.89%
FCFM 49.63%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-13.04%
OM growth 5Y-6.45%
PM growth 3YN/A
PM growth 5Y14.26%
GM growth 3Y-13.4%
GM growth 5Y-6.64%
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 18.61
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.3
Cash Conversion N/A
Profit Quality 145.94%
Current Ratio 2.2
Quick Ratio 2.2
Altman-Z 0.82
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.44%
EPS 3YN/A
EPS 5Y11.84%
EPS Q2Q%-97.37%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.46%
Revenue growth 3Y0.45%
Revenue growth 5Y-2.23%
Sales Q2Q%0%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.16%
EBIT growth 3Y-12.65%
EBIT growth 5Y-8.54%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-52.68%
FCF growth 3Y-16.33%
FCF growth 5Y-9.67%
OCF growth 1Y-52.68%
OCF growth 3Y-16.33%
OCF growth 5Y-9.67%